AssayIndex
Reports by quarter

Reports submitted in 2026-Q2 · page 10

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →

1,126 records29 pagesmedian on this page 99.08 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042059TirzepatideHYBHYB-2512-W7237Janoshik2026-Q298.886.59—Buyer-sourced1MARGINAL
AX-2026-042057TirzepatideHYBHYB-2512-W7237VendorInvestigate2026-Q298.626.36—Buyer-sourced1FAIL
AX-2026-041796SS-31 (Elamipretide)ASYASY-{CAT}-2139Janoshik2026-Q299.766.0999.4Buyer-sourced0PASS
AX-2026-041708BPC-157TFSTFS-{CAT}-9814Medutest2026-Q299.394.21—Buyer-sourced0PASS
AX-2026-041590SemaglutideQSCQSC-2511-M8005PeptideMeter2026-Q299.503.9388.6Buyer-sourced1MARGINAL
AX-2026-041350BPC-157WWBWWB-2604-B3510Janoshik2026-Q299.764.13—Buyer-sourced1MARGINAL
AX-2026-043634CJC-1295 (no DAC)PPGPPG-2512-D7211Janoshik2026-Q299.935.06—Buyer-sourced0PASS
AX-2026-043555CagrilintideSIGSIG-2603-6212Janoshik2026-Q298.694.94—Buyer-sourced0PASS
AX-2026-043551CagrilintideSIGSIG-2603-6212Janoshik2026-Q297.905.04—Buyer-sourced0PASS
AX-2026-043263TirzepatideCPCCPC-2605-P1014Janoshik2026-Q298.474.61—Supplier-supplied1MARGINAL
AX-2026-043134BPC-157SSASSA-2601-N6863Medutest2026-Q297.894.01—Buyer-sourced1FAIL
AX-2026-0430455-Amino-1MQKPKP-2511-W5347Janoshik2026-Q299.474.08—Buyer-sourced0FAIL
AX-2026-042770SemaxGGPepsGGPE-2512-Y1048Nordanalyt2026-Q299.347.75—Buyer-sourced0PASS
AX-2026-042459RetatrutideHomopeptideHOMO-2512-D4932Medutest2026-Q299.313.92—Buyer-sourced1MARGINAL
AX-2026-042419GlucagonHomopeptideHOMO-2602-V3961Janoshik2026-Q299.216.84—Buyer-sourced0PASS
AX-2026-042388TirzepatideHomopeptideHOMO-2601-N4081Nordanalyt2026-Q299.055.3497.2Buyer-sourced0PASS
AX-2026-041957SermorelinAMBAMB-2512-V5420VendorInvestigate2026-Q299.114.02—Buyer-sourced0PASS
AX-2026-041745CagrilintideTFSTFS-{CAT}-1681VendorInvestigate2026-Q298.594.51—Buyer-sourced1FAIL
AX-2026-041367SemaglutideWWBWWB-2512-T3671VendorInvestigate2026-Q298.952.57102.4Buyer-sourced0PASS
AX-2026-041285SemaglutideWWBWWB-2603-N3120Janoshik2026-Q298.466.9499.0Buyer-sourced1MARGINAL
AX-2026-043383MOTS-cWXTWXT-2511-P3368Janoshik2026-Q298.464.70—Supplier-supplied1MARGINAL
AX-2026-043229ARA-290SGNSGN-2605-X9069Janoshik2026-Q298.217.43—Buyer-sourced0PASS
AX-2026-043203GHK-CuSGNSGN-2603-X8452Medutest2026-Q298.533.88—Buyer-sourced0PASS
AX-2026-043150SemaxSSASSA-2604-L7739VendorInvestigate2026-Q298.708.9796.7Buyer-sourced1MARGINAL
AX-2026-0430435-Amino-1MQKPKP-2511-W5347Janoshik2026-Q299.584.16101.1Buyer-sourced0FAIL
AX-2026-042916RetatrutideGGPepsGGPE-2604-X3153VendorInvestigate2026-Q298.165.83—Buyer-sourced0PASS
AX-2026-042806RetatrutideGGPepsGGPE-2512-D2133PeptideMeter2026-Q299.243.50105.4Supplier-supplied0PASS
AX-2026-042589BPC-157HJHJ-2511-U6485PeptideMeter2026-Q298.905.2193.3Laboratory-retained0PASS
AX-2026-042571IpamorelinHJHJ-2604-T6645Janoshik2026-Q298.415.34104.9Buyer-sourced0FAIL
AX-2026-042568IpamorelinHJHJ-2604-T6645Janoshik2026-Q298.995.14—Buyer-sourced0FAIL
AX-2026-042329Enclomiphene citrateTFCTFC-2605-H2745Nordanalyt2026-Q299.413.67—Buyer-sourced2FAIL
AX-2026-041962PT-141 (Bremelanotide)AMBAMB-2601-M5602VendorInvestigate2026-Q299.933.36—Buyer-sourced0PASS
AX-2026-041852PT-141 (Bremelanotide)GSPGSP-2512-N3921Nordanalyt2026-Q299.625.4490.6Buyer-sourced0PASS
AX-2026-041802ExenatideASYASY-{CAT}-2827Janoshik2026-Q299.444.12106.6Buyer-sourced0PASS
AX-2026-041795SS-31 (Elamipretide)ASYASY-{CAT}-2139Nordanalyt2026-Q299.815.64—Buyer-sourced0PASS
AX-2026-041690SemaglutideTFSTFS-{CAT}-9744Janoshik2026-Q298.276.74—Buyer-sourced0PASS
AX-2026-041687SemaglutideTFSTFS-{CAT}-9744Janoshik2026-Q298.026.04—Buyer-sourced0PASS
AX-2026-041387BPC-157QYBQYB-2601-D3993Medutest2026-Q299.934.36102.5Buyer-sourced0PASS
AX-2026-041370DihexaWWBWWB-2601-C4091Kestrel2026-Q299.9311.05—Buyer-sourced0PASS
AX-2026-041259SemaglutideWWBWWB-2604-J2590Nordanalyt2026-Q299.706.85—Laboratory-retained0PASS